Literature DB >> 22789991

Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem.

Ge-Fei Hao1, Guang-Fu Yang, Chang-Guo Zhan.   

Abstract

Drug resistance has become one of the biggest challenges in drug discovery and/or development and has attracted great research interests worldwide. During the past decade, computational strategies have been developed to predict target mutation-induced drug resistance. Meanwhile, various molecular design strategies, including targeting protein backbone, targeting highly conserved residues and dual/multiple targeting, have been used to design novel inhibitors for combating the drug resistance. In this article we review recent advances in development of computational methods for target mutation-induced drug resistance prediction and strategies for rational design of novel inhibitors that could be effective against the possible drug-resistant mutants of the target.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22789991      PMCID: PMC3535271          DOI: 10.1016/j.drudis.2012.06.018

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  53 in total

1.  Natural selection and resistance to HIV.

Authors:  P Schliekelman; C Garner; M Slatkin
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

2.  Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.

Authors:  Ekachai Jenwitheesuk; Ram Samudrala
Journal:  Antivir Ther       Date:  2005

Review 3.  Designed multiple ligands. An emerging drug discovery paradigm.

Authors:  Richard Morphy; Zoran Rankovic
Journal:  J Med Chem       Date:  2005-10-20       Impact factor: 7.446

4.  Combating susceptibility to drug resistance: lessons from HIV-1 protease.

Authors:  Nancy M King; Moses Prabu-Jeyabalan; Ellen A Nalivaika; Celia A Schiffer
Journal:  Chem Biol       Date:  2004-10

Review 5.  Computer prediction of drug resistance mutations in proteins.

Authors:  Zhi Wei Cao; Lian Yi Han; Chan Juan Zheng; Zhi Lang Ji; Xin Chen; Hong Huang Lin; Yu Zong Chen
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851

6.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

Authors:  J M Coffin
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

Review 7.  Inhibitors of multidrug resistance to antitumor agents (MDR).

Authors:  Carmen Avendaño; J Carlos Menéndez
Journal:  Curr Med Chem       Date:  2002-01       Impact factor: 4.530

Review 8.  Death receptor ligands, in particular TRAIL, to overcome drug resistance.

Authors:  S de Jong; T Timmer; F J Heijenbrok; E G de Vries
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

Review 9.  Molecular mechanisms of drug resistance.

Authors:  D B Longley; P G Johnston
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

10.  High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains.

Authors:  Yunfeng Tie; Peter I Boross; Yuan-Fang Wang; Laquasha Gaddis; Azhar K Hussain; Sofiya Leshchenko; Arun K Ghosh; John M Louis; Robert W Harrison; Irene T Weber
Journal:  J Mol Biol       Date:  2004-04-23       Impact factor: 5.469

View more
  12 in total

1.  Protein design algorithms predict viable resistance to an experimental antifolate.

Authors:  Stephanie M Reeve; Pablo Gainza; Kathleen M Frey; Ivelin Georgiev; Bruce R Donald; Amy C Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-31       Impact factor: 11.205

2.  Mechanistic insights into the substrate recognition of PPO: toward the rational design of effective inhibitors.

Authors:  Ge-Fei Hao; Chang-Guo Zhan; Guang-Fu Yang
Journal:  Future Med Chem       Date:  2014-04       Impact factor: 3.808

Review 3.  Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.

Authors:  Ashley N Matthew; Florian Leidner; Gordon J Lockbaum; Mina Henes; Jacqueto Zephyr; Shurong Hou; Desaboini Nageswara Rao; Jennifer Timm; Linah N Rusere; Debra A Ragland; Janet L Paulsen; Kristina Prachanronarong; Djade I Soumana; Ellen A Nalivaika; Nese Kurt Yilmaz; Akbar Ali; Celia A Schiffer
Journal:  Chem Rev       Date:  2021-01-07       Impact factor: 60.622

Review 4.  Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance.

Authors:  Xiaohong Tian; Yang He; Jinming Zhou
Journal:  Front Pharmacol       Date:  2015-03-24       Impact factor: 5.810

5.  EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib.

Authors:  Lichun Ma; Debby D Wang; Yiqing Huang; Hong Yan; Maria P Wong; Victor H F Lee
Journal:  BMC Bioinformatics       Date:  2015-03-14       Impact factor: 3.169

6.  Reverse Chemical Genetics: Comprehensive Fitness Profiling Reveals the Spectrum of Drug Target Interactions.

Authors:  Lai H Wong; Sunita Sinha; Julien R Bergeron; Joseph C Mellor; Guri Giaever; Patrick Flaherty; Corey Nislow
Journal:  PLoS Genet       Date:  2016-09-02       Impact factor: 5.917

Review 7.  Quantum mechanics implementation in drug-design workflows: does it really help?

Authors:  Olayide A Arodola; Mahmoud Es Soliman
Journal:  Drug Des Devel Ther       Date:  2017-08-31       Impact factor: 4.162

8.  High Content Screening Using New U2OS Reporter Cell Models Identifies Harmol Hydrochloride as a Selective and Competitive Antagonist of the Androgen Receptor.

Authors:  Hadjer Dellal; Abdelhay Boulahtouf; Elina Alaterre; Alice Cuenant; Marina Grimaldi; William Bourguet; Céline Gongora; Patrick Balaguer; Philippe Pourquier
Journal:  Cells       Date:  2020-06-16       Impact factor: 6.600

9.  Personalized prediction of EGFR mutation-induced drug resistance in lung cancer.

Authors:  Debby D Wang; Weiqiang Zhou; Hong Yan; Maria Wong; Victor Lee
Journal:  Sci Rep       Date:  2013-10-04       Impact factor: 4.379

10.  Identifying EGFR mutation-induced drug resistance based on alpha shape model analysis of the dynamics.

Authors:  Lichun Ma; Bin Zou; Hong Yan
Journal:  Proteome Sci       Date:  2016-09-08       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.